Australia and New Zealand Faculty of Radiation Oncology Lung Interest Cooperative: 2015 consensus guidelines for the use of advanced technologies in the radiation therapy treatment of locally advanced non‐small cell lung cancer
“…It is of concern that 29% of departments did not have a tumour volume delineation protocol. It may be that some of these departments use published recommendations such as European Society of Therapeutic Radiation Oncology (ESTRO) or FROLIC . However, these recommendations do have to be tailored to local radiotherapy imaging and planning systems, and so specific departmental guidelines are preferable.…”
Section: Discussionmentioning
confidence: 99%
“…ESTRO and Australian radiotherapy guidelines recommend ‘Total lung – GTV’ for lung DVH calculations whilst ASTRO guidelines do not comment on this . In the setting of 4DCT, the definition of GTV is unclear; is it on one phase of the respiratory cycle or all phases?…”
Introduction: In the 4DCT era, the definition of lung organ-at-risk (OAR) volumes for dose-volume histogram (DVH) calculation is unclear, introducing potential for variability in practice. We aimed to identify definitions used clinically and evaluate the magnitude of DVH differences between these. Methods: We surveyed Australian & New Zealand departments about lung radiotherapy protocols including lung OAR volume definition. We used these definitions to calculate lung DVHs on 10 patients prescribed lung IMRT (60-66 Gy/30-33 fractions). We calculated mean lung dose (MLD), V20 and V30 for 'Lungs -PTV', 'Lungs -CTV', 'Lungs -iGTV' (internal GTV in all respiratory phases) and 'Lungs -GTV_EX' (expiratory phase). Results: The response rate was 39% (34/88). 14% and 29% of departments did not have a departmental protocol for OAR and tumour volume delineation, respectively. All permutations for lung OAR volumes were used with no clear preference. For conventional radiotherapy (n = 27), this included Lungs alone (n = 1), Lungs -PTV (n = 6), Lungs -CTV (n = 2), Lungs -iGTV (n = 6), Lungs -GTV in single phase (n = 5) and individual clinician preference (n = 7). The different lung OAR volumes resulted in MLD difference ranging from 0.9 to 4.15 Gy, V20 from 1.5% to 6.6% and V30 from 1.34% to 7.11%. The largest differences between subtraction of GTV_EX and iGTV were 0.32 Gy, 0.43% and 0.46% for MLD, V20 and V30, respectively. Conclusion: A significant number of departments lacked lung cancer radiotherapy contouring protocols. Lung OAR volume definition was variable between and within departments. Potentially clinically significant differences in lung DVH parameters were seen according to the volume used.
“…It is of concern that 29% of departments did not have a tumour volume delineation protocol. It may be that some of these departments use published recommendations such as European Society of Therapeutic Radiation Oncology (ESTRO) or FROLIC . However, these recommendations do have to be tailored to local radiotherapy imaging and planning systems, and so specific departmental guidelines are preferable.…”
Section: Discussionmentioning
confidence: 99%
“…ESTRO and Australian radiotherapy guidelines recommend ‘Total lung – GTV’ for lung DVH calculations whilst ASTRO guidelines do not comment on this . In the setting of 4DCT, the definition of GTV is unclear; is it on one phase of the respiratory cycle or all phases?…”
Introduction: In the 4DCT era, the definition of lung organ-at-risk (OAR) volumes for dose-volume histogram (DVH) calculation is unclear, introducing potential for variability in practice. We aimed to identify definitions used clinically and evaluate the magnitude of DVH differences between these. Methods: We surveyed Australian & New Zealand departments about lung radiotherapy protocols including lung OAR volume definition. We used these definitions to calculate lung DVHs on 10 patients prescribed lung IMRT (60-66 Gy/30-33 fractions). We calculated mean lung dose (MLD), V20 and V30 for 'Lungs -PTV', 'Lungs -CTV', 'Lungs -iGTV' (internal GTV in all respiratory phases) and 'Lungs -GTV_EX' (expiratory phase). Results: The response rate was 39% (34/88). 14% and 29% of departments did not have a departmental protocol for OAR and tumour volume delineation, respectively. All permutations for lung OAR volumes were used with no clear preference. For conventional radiotherapy (n = 27), this included Lungs alone (n = 1), Lungs -PTV (n = 6), Lungs -CTV (n = 2), Lungs -iGTV (n = 6), Lungs -GTV in single phase (n = 5) and individual clinician preference (n = 7). The different lung OAR volumes resulted in MLD difference ranging from 0.9 to 4.15 Gy, V20 from 1.5% to 6.6% and V30 from 1.34% to 7.11%. The largest differences between subtraction of GTV_EX and iGTV were 0.32 Gy, 0.43% and 0.46% for MLD, V20 and V30, respectively. Conclusion: A significant number of departments lacked lung cancer radiotherapy contouring protocols. Lung OAR volume definition was variable between and within departments. Potentially clinically significant differences in lung DVH parameters were seen according to the volume used.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.